Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Structure-property relationship of Co2MnSi thin films in response to He+-irradiation.

Hammerath F, Bali R, Hübner R, Brandt MRD, Rodan S, Potzger K, Böttger R, Sakuraba Y, Wurmehl S.

Sci Rep. 2019 Feb 26;9(1):2766. doi: 10.1038/s41598-019-39435-4.

2.

52g/55Mn-Labelled CDTA-based trimeric complexes as novel bimodal PET/MR probes with high relaxivity.

Brandt MR, Vanasschen C, Ermert J, Coenen HH, Neumaier B.

Dalton Trans. 2019 Feb 26;48(9):3003-3008. doi: 10.1039/c8dt04996c.

PMID:
30747205
3.

Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Cav 2.2) blockers for the treatment of pain.

Wall MJ, Subasinghe NL, Winters MP, Lubin ML, Finley MFA, Qin N, Brandt MR, Neeper MP, Schneider CR, Colburn RW, Flores CM, Sui Z.

Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3780-3783. doi: 10.1016/j.bmcl.2018.10.007. Epub 2018 Oct 12.

PMID:
30337231
4.

Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep).

Parsons WH, Calvo RR, Cheung W, Lee YK, Patel S, Liu J, Youngman MA, Dax SL, Stone D, Qin N, Hutchinson T, Lubin ML, Zhang SP, Finley M, Liu Y, Brandt MR, Flores CM, Player MR.

J Med Chem. 2015 May 14;58(9):3859-74. doi: 10.1021/acs.jmedchem.5b00132. Epub 2015 Apr 15.

PMID:
25850459
5.

Discovery and SAR of a novel series of 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles as N-type calcium channel inhibitors.

Winters MP, Subasinghe N, Wall M, Beck E, Brandt MR, Finley MF, Liu Y, Lubin ML, Neeper MP, Qin N, Flores CM, Sui Z.

Bioorg Med Chem Lett. 2014 May 1;24(9):2057-61. doi: 10.1016/j.bmcl.2014.03.063. Epub 2014 Mar 28.

PMID:
24726803
6.

Discovery and SAR of novel tetrahydropyrrolo[3,4-c]pyrazoles as inhibitors of the N-type calcium channel.

Winters MP, Subasinghe N, Wall M, Beck E, Brandt MR, Finley MF, Liu Y, Lubin ML, Neeper MP, Qin N, Flores CM, Sui Z.

Bioorg Med Chem Lett. 2014 May 1;24(9):2053-6. doi: 10.1016/j.bmcl.2014.03.062. Epub 2014 Mar 27.

PMID:
24726802
7.

Adenovirus vector-mediated RNA interference for the inhibition of human parvovirus B19 replication.

Brandt MR, Kirste AG, Pozzuto T, Schubert S, Kandolf R, Fechner H, Bock CT, Kurreck J.

Virus Res. 2013 Sep;176(1-2):155-60. doi: 10.1016/j.virusres.2013.05.020. Epub 2013 Jun 13.

PMID:
23770153
8.

Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists.

Zhu B, Xia M, Xu X, Ludovici DW, Tennakoon M, Youngman MA, Matthews JM, Dax SL, Colburn RW, Qin N, Hutchinson TL, Lubin ML, Brandt MR, Stone DJ, Flores CM, Macielag MJ.

Bioorg Med Chem Lett. 2013 Apr 1;23(7):2234-7. doi: 10.1016/j.bmcl.2013.01.062. Epub 2013 Feb 4.

PMID:
23411075
9.

A novel series of pyrazolylpiperidine N-type calcium channel blockers.

Subasinghe NL, Wall MJ, Winters MP, Qin N, Lubin ML, Finley MF, Brandt MR, Neeper MP, Schneider CR, Colburn RW, Flores CM, Sui Z.

Bioorg Med Chem Lett. 2012 Jun 15;22(12):4080-3. doi: 10.1016/j.bmcl.2012.04.075. Epub 2012 May 2.

PMID:
22608964
10.

The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.

Matthews JM, Qin N, Colburn RW, Dax SL, Hawkins M, McNally JJ, Reany L, Youngman MA, Baker J, Hutchinson T, Liu Y, Lubin ML, Neeper M, Brandt MR, Stone DJ, Flores CM.

Bioorg Med Chem Lett. 2012 Apr 15;22(8):2922-6. doi: 10.1016/j.bmcl.2012.02.060. Epub 2012 Feb 27.

PMID:
22421018
11.

TRPV1 Antagonists and Chronic Pain: Beyond Thermal Perception.

Brandt MR, Beyer CE, Stahl SM.

Pharmaceuticals (Basel). 2012 Feb 2;5(2):114-32. doi: 10.3390/ph5020114.

12.

Diabetogenic effect of a series of tricyclic delta opioid agonists structurally related to cyproheptadine.

Codd EE, Baker J, Brandt MR, Bryant S, Cai C, Carson JR, Chevalier KM, Colburn RW, Coogan TP, Dax SL, Decorte B, Kemmerer M, Legrand EK, Lenhard JM, Leone AM, Lin L, Mabus JR, McDonnell ME, McMillian MK, McNally JJ, Stone DJ Jr, Wang CY, Zhang SP, Flores CM.

Toxicol Sci. 2010 Oct;117(2):493-504. doi: 10.1093/toxsci/kfq200. Epub 2010 Jul 8.

PMID:
20616206
13.

Ex vivo delta opioid receptor autoradiography: CNS receptor occupancy of two novel compounds over their antihyperalgesic dose range.

Codd EE, Ma J, Zhang SP, Stone DJ Jr, Colburn RW, Brandt MR, Chevalier KM, Zhu Y, Peng S, Cai C, Acton PD, Flores CM.

Pharmacol Biochem Behav. 2010 Aug;96(2):130-5. doi: 10.1016/j.pbb.2010.04.020. Epub 2010 May 12.

PMID:
20438745
14.

Prodrugs of perzinfotel with improved oral bioavailability.

Baudy RB, Butera JA, Abou-Gharbia MA, Chen H, Harrison B, Jain U, Magolda R, Sze JY, Brandt MR, Cummons TA, Kowal D, Pangalos MN, Zupan B, Hoffmann M, May M, Mugford C, Kennedy J, Childers WE Jr.

J Med Chem. 2009 Feb 12;52(3):771-8. doi: 10.1021/jm8011799.

PMID:
19146418
15.

Discovery of piperidine carboxamide TRPV1 antagonists.

Cheung WS, Calvo RR, Tounge BA, Zhang SP, Stone DR, Brandt MR, Hutchinson T, Flores CM, Player MR.

Bioorg Med Chem Lett. 2008 Aug 15;18(16):4569-72. doi: 10.1016/j.bmcl.2008.07.035. Epub 2008 Jul 15.

PMID:
18662879
16.

N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1).

Jetter MC, McNally JJ, Youngman MA, McDonnell ME, Dubin AE, Nasser N, Zhang SP, Codd EE, Colburn RW, Stone DR, Brandt MR, Flores CM, Dax SL.

Bioorg Med Chem Lett. 2008 Apr 15;18(8):2730-4. doi: 10.1016/j.bmcl.2008.02.075. Epub 2008 Mar 5. Erratum in: Bioorg Med Chem Lett. 2008 Jul 15;18(14):4254.

PMID:
18359227
17.

Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.

Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B, Brandt MR, Dawson LA, Cole D, Bernotas R, Robichaud A, Rosenzweig-Lipson S, Beyer CE.

Neuropsychopharmacology. 2008 May;33(6):1323-35. Epub 2007 Jul 11.

18.

Attenuated cold sensitivity in TRPM8 null mice.

Colburn RW, Lubin ML, Stone DJ Jr, Wang Y, Lawrence D, D'Andrea MR, Brandt MR, Liu Y, Flores CM, Qin N.

Neuron. 2007 May 3;54(3):379-86.

19.

Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain.

Leventhal L, Smith V, Hornby G, Andree TH, Brandt MR, Rogers KE.

J Pharmacol Exp Ther. 2007 Mar;320(3):1178-85. Epub 2006 Dec 1.

PMID:
17142646
20.

An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain.

Leventhal L, Brandt MR, Cummons TA, Piesla MJ, Rogers KE, Harris HA.

Eur J Pharmacol. 2006 Dec 28;553(1-3):146-8. Epub 2006 Sep 26.

PMID:
17056036
21.

Preclinical assessment of candidate analgesic drugs: recent advances and future challenges.

Negus SS, Vanderah TW, Brandt MR, Bilsky EJ, Becerra L, Borsook D.

J Pharmacol Exp Ther. 2006 Nov;319(2):507-14. Epub 2006 Jun 2. Review.

PMID:
16751251
22.

Neurochemical changes in the RVM associated with peripheral inflammatory pain stimuli.

Smith VA, Beyer CE, Brandt MR.

Brain Res. 2006 Jun 20;1095(1):65-72. Epub 2006 May 30.

PMID:
16730668
23.

Effects of the N-methyl-D-aspartate receptor antagonist perzinfotel [EAA-090; [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid] on chemically induced thermal hypersensitivity.

Brandt MR, Cummons TA, Potestio L, Sukoff SJ, Rosenzweig-Lipson S.

J Pharmacol Exp Ther. 2005 Jun;313(3):1379-86. Epub 2005 Mar 11.

PMID:
15764736
25.

Delta opioid antagonist effects of buprenorphine in rhesus monkeys.

Negus SS, Bidlack JM, Mello NK, Furness MS, Rice KC, Brandt MR.

Behav Pharmacol. 2002 Nov;13(7):557-70.

PMID:
12409994
26.

Characterization of the discriminative stimulus effects of buprenorphine in pigeons.

Galici R, Brandt MR, France CP.

Psychopharmacology (Berl). 2002 Mar;160(2):132-9. Epub 2002 Jan 22.

PMID:
11875630
27.

Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation.

Brandt MR, Furness MS, Rice KC, Fischer BD, Negus SS.

J Pharmacol Exp Ther. 2001 Nov;299(2):629-37.

PMID:
11602675
28.

Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity.

Brandt MR, Furness MS, Mello NK, Rice KC, Negus SS.

J Pharmacol Exp Ther. 2001 Mar;296(3):939-46.

PMID:
11181927
30.
31.

Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys.

Negus SS, Brandt MR, Mello NK.

J Pharmacol Exp Ther. 1999 Oct;291(1):60-9.

PMID:
10490887
32.

Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys.

Brandt MR, Negus SS, Mello NK, Furness MS, Zhang X, Rice KC.

J Pharmacol Exp Ther. 1999 Sep;290(3):1157-64.

PMID:
10454490
33.
34.

[Crisis intervention/debriefing--flop or fact?].

Brandt MR.

Ugeskr Laeger. 1998 Sep 21;160(39):5682-3. Danish. No abstract available.

PMID:
9771074
35.

Pharmacological profile of a deuterium-substituted mirfentanil derivative, OHM10579, in rhesus monkeys.

Lelas S, Gerak LR, Landers LK, Brandt MR, Bagley JR, Brockunier LL, France CP.

Pharmacol Biochem Behav. 1998 Jul;60(3):665-75.

PMID:
9678650
36.
37.

Behavioral effects and binding affinities of the fentanyl derivative OHM3507.

France CP, Ahn SC, Brockunier LL, Bagley JR, Brandt MR, Winsauer PJ, Moerschbaecher JM.

Pharmacol Biochem Behav. 1998 Feb;59(2):295-303.

PMID:
9476973
38.
39.

[Intraosseous administration].

Brandt MR.

Ugeskr Laeger. 1996 Sep 30;158(40):5638. Danish. No abstract available.

PMID:
8966797
40.

Discriminative stimulus effects on enadoline in pigeons.

Brandt MR, France CP.

J Pharmacol Exp Ther. 1996 May;277(2):960-7.

PMID:
8627579
41.

[Attitude to the criteria of death and kidney transplantation of the relatives of kidney donors].

Nielsen G, Brandt MR.

Ugeskr Laeger. 1990 Mar 19;152(12):806-9. Danish.

PMID:
2316036
42.

Mental function in elderly men after surgery during epidural analgesia.

Asbjørn J, Jakobsen BW, Pilegaard HK, Blom L, Ostergaard A, Brandt MR.

Acta Anaesthesiol Scand. 1989 Jul;33(5):369-73.

PMID:
2800973
43.

[Comments on the article about anesthetic gases research: statement lacks proof for the need to lower threshold limit values].

Brandt MR, Mortensen H.

Sygeplejersken. 1982 Dec 1;82(47):24-5. Danish. No abstract available.

PMID:
6926288
44.

Extradural morphine and Stokes-Adams attacks.

Christensen P, Brandt MR.

Br J Anaesth. 1982 Mar;54(3):363. No abstract available.

PMID:
7066133
45.

Influence of extradural morphine on the adrenocortical and hyperglycaemic response to surgery.

Christensen P, Brandt MR, Rem J, Kehlet H.

Br J Anaesth. 1982 Jan;54(1):23-7.

46.

Influence of epidural analgesia on postoperative changes in various serum enzyme patterns and serum bilirubin.

Rem J, Møller IW, Brandt MR, Kehlet H.

Acta Anaesthesiol Scand. 1981 Apr;25(2):142-5.

PMID:
7324821
47.

Postoperative changes in coagulation and fibrinolysis independent of neurogenic stimuli and adrenal hormones.

Rem J, Feddersen C, Brandt MR, Kehlet H.

Br J Surg. 1981 Apr;68(4):229-33.

PMID:
7225737
48.

Prolactin, LH, FSH, GH and cortisol response to surgery and the effect of epidural analgesia.

Hagen C, Brandt MR, Kehlet H.

Acta Endocrinol (Copenh). 1980 Jun;94(2):151-4.

PMID:
6774546
49.

Role of neurogenic stimuli in mediating the endocrine-metabolic response to surgery.

Kehlet H, Brandt MR, Rem J.

JPEN J Parenter Enteral Nutr. 1980 Mar-Apr;4(2):152-6. No abstract available.

PMID:
6995626
50.

Prevention of postoperative lymphopenia and granulocytosis by epidural analgesia.

Rem J, Brandt MR, Kehlet H.

Lancet. 1980 Feb 9;1(8163):283-4.

PMID:
6101739

Supplemental Content

Loading ...
Support Center